Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Na ïve Individuals
Condition:   Influenza Intervention:   Biological: H5N1 pISV Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source:
Source: - January 25, 2019 Category: Research Source Type: clinical trials